Full Text View
Tabular View
No Study Results Posted
Related Studies
Chronic Obstructive Pulmonary Disease Gene Localization
This study has been completed.
Study NCT00037739   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: May 20, 2002   Last Updated: June 23, 2005   History of Changes

May 20, 2002
June 23, 2005
April 2001
 
 
 
Complete list of historical versions of study NCT00037739 on ClinicalTrials.gov Archive Site
 
 
 
Chronic Obstructive Pulmonary Disease Gene Localization
 

To localize within the genome a chronic obstructive pulmonary disease susceptibility gene.

BACKGROUND:

Chronic obstructive pulmonary disease (COPD) is a slowly progressive disorder characterized by airways obstruction that lasts for at least several months. The two major causes of COPD are chronic bronchitis and emphysema. Either disorder may occur with or without airways obstruction, but airways obstruction causes impairment of lung function leading to disability and death. COPD is a major health problem in the United States and throughout the world, consistently ranking among the most common causes of death in the United States. Cigarette smoking is the primary environmental factor that increases the risk of COPD, but other environmental factors have also been implicated. However, despite a well-established role, environmental factors alone do not cause COPD. Symptomatic COPD develops in only 10-20 percent of heavy cigarette smokers, probably those with a genetic susceptibility, although common COPD susceptibility genes have yet to be identified.

DESIGN NARRATIVE:

The study applied statistical linkage analysis to family data. Pulmonary measurements had already been collected on 159 members of 16 pedigrees and evidence supporting a COPD susceptibility gene in these pedigrees had been obtained from segregation analysis. Each of 11,995 genetic markers, which had already been genotyped on pedigree members, were tested for evidence of linkage to the inferred COPD susceptibility gene. Evidence of linkage to one or more genetic markers identifed genomic locations of COPD susceptibility genes. The high density of markers allowed fine-mapping of the gene. Successful completion of this gene localization project was the necessary prerequisite for a project to identify and characterize a COPD susceptibility gene. Identifying a gene that when mutated increased the risk of COPD may increase understanding of pulmonary function, as well as allowing gene-carriers to be identified and made aware of their susceptibility.

 
Observational
Natural History, Defined Population
  • Lung Diseases
  • Chronic Obstructive Pulmonary Disease
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
March 2004
 

No eligibility criteria

Both
 
No
Contact information is only displayed when the study is recruiting subjects
 
 
NCT00037739
 
1175
National Heart, Lung, and Blood Institute (NHLBI)
 
Investigator: Sandra Hasstedt University of Utah
National Heart, Lung, and Blood Institute (NHLBI)
May 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP